Preventing the next generation of extensively drug-resistant tuberculosis

International Journal of Tuberculosis and Lung Disease

Volumn 14, Issue 5, 2010, Pages 525-527

  Amor, Y Ben ^a   Day, M S ^b   Schluger, N W ^c  

^a Center for International Forestry Research   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c Columbia University College of Physicians and Surgeons ^*  (United States)

Author keywords

Drug development; MDR TB; XDR TB

Indexed keywords

ANTIMYCOBACTERIAL AGENT; ISONIAZID; QUINOLONE DERIVATIVE; RIFAMPICIN; STREPTOMYCIN;

BACTERIAL STRAIN; DIAGNOSIS; DRUG DEVELOPMENT; DRUG RESISTANT TUBERCULOSIS; DRUG SENSITIVITY; GENE MUTATION; HEALTH CARE PERSONNEL; MICROSCOPY; MORBIDITY; MORTALITY; PATIENT COMPLIANCE; POLYMERASE CHAIN REACTION; PRESCRIPTION; PRIORITY JOURNAL; SHORT SURVEY; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; DRUG DELIVERY SYSTEMS; DRUG DESIGN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS; HUMANS; MICROBIAL SENSITIVITY TESTS;

EID: 77950875555     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (9)

1. Centers for Disease Control and Prevention. Emergence of Myco-bacterium tuberculosis with extensive resistance to second-line drugs\worldwide 2000-2004. MMWR 2006; 55: 301-305.
2. World Health Organization. Anti-tuberculosis drug resistance in the world. Report no 4. WHO/HTM/TB/2008.394. Geneva, Switzerland: WHO, 2008.
3. Keshavjee S, Gelmanova I Y, Farmer P E, et al. Treatment of extensively drug-resistant tuberculosis in Tomsk, Russia: a retrospective cohort study. Lancet 2008; 372: 1403-1409.
4. Mitnick C D, Shin S S, Seung K J, et al. Comprehensive treatment of extensively drug-resistant tuberculosis. N Engl J Med 2008; 359: 563-574.
5. Fox W, Ellard G A, Mitchison D A. Studies on the treatment of tuberculosis undertaken by the British Medical Research Council tuberculosis units, 1946-1986, with relevant subsequent publications. Int J Tuberc Lung Dis 1999; 3 (Suppl 2): S231-S279. (Pubitemid 29481843)
6. Enarson D A, Chiang C-Y, Murray J F. Global epidemiology of tuberculosis. In: Rom W N, Garay S M, eds. Tuberculosis. Philadelphia, PA, USA: Lippincott Williams & Wilkins, 2004: p 13-29.
7. Davies P D, Pai M. The diagnosis and misdiagnosis of tuberculosis. Int J Tuberc Lung Dis 2008; 12: 1226-1234.
8. Ginsberg A M, Spigelman M. Challenges in tuberculosis drug research and development. Nat Med 2007; 13: 290-294. (Pubitemid 46376672)
9. Pai M, O'Brien R. New diagnostics for latent and active tuberculosis: state of the art and future prospects. Semin Respir Crit Care Med 2008; 29: 560-568.